View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Research suggests that in some forms of Alzheimer's disease, brain cells lose the ability to use glucose for energy. In promising research, a milkshake-like drug loaded with fatty acids provided an alternative food source for hungry neurons.
Researchers conducted a randomized, double-blind, placebo-controlled study involving 152 people with Alzheimer's disease at 25 centers across the United States. The researchers found that many of those who drank a drug concoction called Ketasyn enjoyed small but noticeable improvements in mental function. (The patients continued taking their regular medications for Alzheimer's disease, such as acetylcholinesterase inhibitors, as prescribed.) The greatest improvement was found in patients without the ApoE4 genotype, a genetic risk factor for Alzheimer's disease.
Ketasyn is one of four drugs on the verge of large-scale testing as treatments for Alzheimer's disease. Researchers reported their findings at an international meeting of Alzheimer's disease researchers in Washington, D.C., in June. For more information about Ketasyn, visit http://www.accerapharma.com/21/news.html.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top